Clinical Trials Sponsored by CSPC-NBP Pharmaceutical Co., Ltd.

Total 3867 results

GeneScience Pharmaceuticals Co., Ltd.
Peking Union Medical College Hospital

Unknown

Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers

Juvenile Idiopathic Arthritis

China
Visen Pharmaceuticals (Shanghai) Co., Ltd.
Ascendis Pharma A/S

Unknown

Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency

Endocrine System Diseases | Pituitary Diseases | Growth Hormone Deficiency | Hormones | Pituitary Disease, Anterior

China
Sun Yat-sen University
Shanghai Pharmaceuticals Holding Co., Ltd

Unknown

Optimal MTX Dose With Folic Acid Randomized Case-control Trial (MTXFARCT)

Rheumatoid Arthritis

China
Li Peng
Betta Pharmaceuticals Co., Ltd.

Completed

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Icotinib)

Neurofibromatosis Type 2 | Vestibular Schwannoma

China
The Ninth Hospital of Nanchang
Ascletis Pharmaceuticals Co., Ltd.

Completed

Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection

COVID-19

China
Peking University Cancer Hospital & Institute
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC

EGFR Positive Non-Small Cell Lung Cancer,Adenocarcinoma

China
Abbott
Rundo-Cronova International Pharmaceuticals Research & Development Co., Ltd.

Completed

Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane

Anesthesia, General

China
Asieris Pharmaceuticals (AUS) Pty Ltd.

Completed

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Bladder Cancer

Australia
Peking Union Medical College Hospital
Betta Pharmaceuticals Co., Ltd.

Recruiting

A Real World Study of Ensartinib in Advanced ALK-positive NSCLC

Carcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma Kinase I1171N | Ensartinib

China
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
LENZ Therapeutics, Inc

Completed

Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia

Presbyopia

China
Kexing Biopharm Co., Ltd.
The Third Hospital of Changsha; Guoxin Pharmaceutical Technology (Beijing)... and other collaborators

Completed

A Phase I Study in Healthy Participants

Healthy Participants

China
Ji Xing Pharmaceuticals Australia Pty Ltd
Novotech (Australia) Pty Limited

Recruiting

JX09 SAD/MAD in Healthy Participants

Resistant Hypertension

Australia
Shanghai Henlius Biotech
Huashan Hospital; Shanghai Fosun Pharmaceutical Industrial Development Co.... and other collaborators

Recruiting

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Ousehold in China

COVID-19

China
Korea Otsuka Pharmaceutical Co., Ltd.
Seoul National University Boramae Hospital; Korea Otsuka International Asia...

Completed

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Cerebral Infarction

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...
Shanghai Junshi Bioscience Co., Ltd.; Qilu Pharmaceutical Co., Ltd.

Unknown

QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer (BEVTOR)

MSS | pMMR | Refractory Metastatic Colorectal Cancer

China
National University Hospital, Singapore
Otsuka Pharmaceutical Co., Ltd.; Shin Nippon Biomedical Laboratories, Ltd.

Terminated

OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy

Nasopharyngeal Carcinoma

Singapore
Shandong New Time Pharmaceutical Co., LTD
Sun Yat-sen University

Not yet recruiting

Phase I Study of LNF1901 in Advanced Malignant Tumors

Advanced Malignant Tumors
Wuhan Union Hospital, China
Yichang Humanwell Pharmaceutical Co., Ltd., China

Recruiting

PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function

Mechanically Ventilated Patients

China
Shanghai Zhongshan Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors (FAITH)

Hepatocellular Carcinoma

China
Fujian Medical University Union Hospital
Beijing Continent Pharmaceutical Co, Ltd.

Recruiting

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

Acute Lung Injury | Prevention

China
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Jilin Provincial Tumor Hospital

Recruiting

A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

Locally Advanced Unresectable Carcinoma

China
Henan Cancer Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Esophageal Neoplasms

China
Guangdong Association of Clinical Trials
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

MRD Guiding Treatment After Almonertinib Induction Therapy for EGFRm+ Stage III NSCLC in the MDT Diagnostic Model. (APPROACH)

Lung Cancer

China
Asan Medical Center
Green Cross Corporation; Boryung Pharmaceutical Co., Ltd

Recruiting

A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

Urachal Cancer

Korea, Republic of
Keio University
Merck Sharp & Dohme LLC; Ohara Pharmaceutical Co., Ltd.

Recruiting

Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma

Melanoma

Japan
Peking University Cancer Hospital & Institute
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Not yet recruiting

Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital

Not yet recruiting

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Advanced Non-small Cell Lung Cancer

China
Ling Zhiqiang
Zhejiang Shouxiangu Pharmaceutical Co,. Ltd.

Completed

Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression

Depression | Thyroid Cancer

China
Biotech Pharmaceutical Co., Ltd.
Fudan University; NanJing PLA 81 Hospital

Completed

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Pancreatic Cancer

China
Peking Union Medical College Hospital
Chengdu Yunke Pharmaceutical Co., Ltd.

Completed

A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis

Arthritis, Psoriatic

China
Peking Union Medical College Hospital
Shijiazhuang Yiling Pharmaceutical Co. Ltd

Unknown

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Epilepsy | Tuberous Sclerosis Complex | Aspirin | Cognitive Decline | Skin Lesions

China
Shanghai Zhangjiang Biotechnology Limited Company
Shanghai Biomabs Pharmaceutical Co., Ltd.

Completed

Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer (CRC009)

Metastatic Colorectal Cancer
Beijing Anzhen Hospital
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Completed

ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction (SF-STEMI)

Myocardial Infarction

China
EMD Serono
Merck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. Ltd

Terminated

Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) (DreaMS)

Multiple Sclerosis

United States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
Chinese PLA General Hospital
Jiangsu Suzhong Pharmaceutical Group Co., Ltd.

Unknown

Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease

Chronic Kidney Disease

China
Xijing Hospital of Digestive Diseases
Beijing Tide Pharmaceutical Co., Ltd

Completed

Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer

Esophageal Neoplasms

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Nanjing Medical University

Completed

A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics (ALTN)

Advanced Cancer

China
Boryung Pharmaceutical Co., Ltd
Yonsei University; Kyungpook National University Hospital

Completed

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Essential Hypertension | Hepatic Impairment

Korea, Republic of
Baohui Han
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns (APPOINT)

Lung Cancer

China
University of California, Irvine
Natera, Inc.; Taiho Pharmaceutical Co., Ltd.

Recruiting

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Colorectal Cancer | Colon Adenocarcinoma

United States
Joint Stock Company "Farmak"
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Recruiting

Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel

Rheumatoid Arthritis

Ukraine
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
Wuhan Union Hospital, China

Completed

A Clinical Study of 68Ga-HX01 Injection for PET Imaging

Healthy | Malignancy

China
Wuhan Union Hospital, China
Yichang Humanwell Pharmaceutical Co., Ltd., China

Completed

Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Mechanically Ventilated Patients

China
Wuhan Union Hospital, China
Yichang Humanwell Pharmaceutical Co., Ltd., China

Completed

Step 2 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients (ShoSReB)

Mechanical Ventilation | Sedative

China
The National Institutes of Pharmaceutical R&D Co...

Completed

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Idiopathic Pulmonary Fibrosis

United States
Shanghai Yinnuo Pharmaceutical Technology Co.,...
Shanghai 6th People's Hospital

Completed

A Study of Supaglutide in Chinese Type 2 Diabetes Patients

Diabetes Mellitus, Type 2

China
AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (MATEO)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

Germany
Peking University First Hospital
Jiangsu Wanbang Pharmaceutical Marketing Co.,Ltd.

Unknown

Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris

Coronary Heart Disease

China
Beijing Tiantan Hospital
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (Endostatin)

Neurofibromatosis Type 2 | Vestibular Schwannoma

China
Zhejiang University
Beta Pharma, Inc.; Jiangsu Simcere Pharmaceutical Co., Ltd.

Unknown

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Lung Cancer

China

Clinical Trials Sponsored by CSPC-NBP Pharmaceutical Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations